Tobacco product regulation and disclosure

Overview of tobacco product regulation and disclosure in Australia.

Page last updated: 05 August 2014

Current measures in Australia

In 2000, the Department negotiated a voluntary agreement for the disclosure of the ingredients of cigarettes with the three tobacco companies, Philip Morris Limited, British American Tobacco Australia Limited and Imperial Tobacco Australia Limited.

In 2001, the three tobacco manufacturers, Philip Morris Limited, British American Tobacco Australia and Imperial Tobacco Australia Ltd, agreed to undertake cigarette emissions testing of selected Australian cigarette brand variants on a one-off basis and to supply the results to the department within the spirit of the voluntary agreement for the disclosure of ingredients of cigarettes.

Since September 2010, all cigarettes in Australia are required to meet a reduced fire propensity standard and packaging is required to state this.

Related links

Current areas of work

Work to support the implementation of guidelines under Articles 9 and 10 of the WHO FCTC

This involves the development of a regulation impact statement on options for the further implementation of guidelines under Articles 9 and 10 of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC). Article 9 relates to the regulation of the contents of tobacco products. Article 10 relates to the regulation of tobacco product disclosures.

This work has included consultation with key stakeholders, including the tobacco industry, non-government organisations particularly those with expertise/interest in tobacco control and Commonwealth, state and territory government agencies.

Electronic nicotine delivery systems (ENDS) and smokeless tobacco

The Department is examining the regulatory framework governing electronic cigarettes (also known as e-cigarettes, e-cigs or ENDS) and smokeless tobacco products in Australia, and will take into account the WHO FCTC’s evidence building work on this issue.

Further information on the WHO FCTC